Spinal Bulbar Muscular Atrophy

Oncology

Prevalence

1.5 / 100K

Incidence

1.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinal Bulbar Muscular Atrophy?

There are 1 clinical trial targeting Spinal Bulbar Muscular Atrophy tracked by BioSniper.

What is the prevalence of Spinal Bulbar Muscular Atrophy?

The estimated prevalence of Spinal Bulbar Muscular Atrophy is approximately 1.5 per 100,000 population.

Deep-dive into Spinal Bulbar Muscular Atrophy

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinal Bulbar Muscular Atrophy — Drugs in Development & Clinical Trials | BioSniper